Questionnaire
movement disorder, movement disorders
MOVEMENT DISORDER, MOVEMENT DISORDERS
A questionnaire was developed by a clinician (TH) and a statistician (HS) and sent to movement disorders specialists experienced in the use of apomorphine. These movement disorder specialists were chosen due to their extensive experience with apomorphine infusion therapy. They represent Thailand, Australia, UK, Spain, Portugal, France, Italy, Austria, Germany, Sweden, Norway, and Denmark, and are listed in full in the supplementary material. A total of 12 questionnaires were sent out. Since the primary author of this article (TH) also completed one, a total of 13 questionnaires were included in the analysis. One responder chose to pass on the questionnaire to a local colleague who was more experienced with apomorphine infusion. The response rate was 100%.The questionnaire included the following aspects:Optional trial administration of apomorphineAnti-emetic useInitiation: inpatient or outpatient; starting dose; dose incrementsReduction of concomitant medicationsMonitoring on established treatmentUse of the pump’s bolus functionThe full questionnaire can be found in the 